More on NVCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.78 |
|
|||
| Open | $15.87 | ||||
| 52 Wk High | $28.95 | ||||
| 52 Wk Low | $5.95 | ||||
| Day High | $17.31 | ||||
| Day Low | $15.61 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,953,474 | ||||
- Form 4 NovoCure Ltd For: Jun 30 Filed by: Puri Michal Nath
- Form 4 NovoCure Ltd For: Jun 30 Filed by: Leonard Frank X
- Form 4 NovoCure Ltd For: Jun 30 Filed by: Ben Arye Barak
- Form 4 NovoCure Ltd For: Jun 30 Filed by: Danziger Asaf
- Novocure to Report Second Quarter 2026 Financial Results
- Form 8-K NovoCure Ltd For: Jun 30
- Novocure's Optune Pax wins CE Mark for pancreatic cancer
- Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
- FreeCast surges premarket; Accenture, Novocure slide
- Novocure's TRIDENT trial misses primary endpoint in glioblastoma
Entities mentioned with NVCR
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
